Sign inJoin waitlistJoin the waitlist

Rolf Kreutz

PROGRAM DIRECTOR · Indiana University School of Medicine

Credentials: · · · · ·

History

Indiana University School of Medicine
Present
Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Sinai Hospital of Baltimore
2005–2006
Cardiovascular Disease
Indiana University School of Medicine
2002–2005
University Hospital Zurich
1999–2002
University of Bern
1995–1999

Research

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study
Journal of the American College of Cardiology · 2005 · 584 citations
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions · 2018 · 250 citations
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
Critical Care Medicine · 2020 · 125 citations

DF
David Flockhart
12 papers
Jeffrey Breall
12 papers
Paul Gurbel
11 papers
Elisabeth von der Lohe
10 papers
Anjan Sinha
9 papers
Richard Kovacs
8 papers
Amber Beitelshees
5 papers
George Stouffer
5 papers
JJ
Julie Johnson
5 papers
Michael Eadon
5 papers · 4 as a resident
PN
Perry Nystrom
5 papers
Ankur Kalra
4 papers · 4 as a fellow

Clinical trials

IU Health Krannert Personalized Medicine Study
Principal investigator · Terminated
Indiana University
2016–2020
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
Principal investigator · Terminated
Indiana University
2008–2014
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2028